{"schema_version":"secwatch.filing_event.v1","accession":"0001510964-22-000016","form_type":"8-K","ticker":"CVSI","cik":"0001510964","company_name":"CV Sciences, Inc.","filed_at":"2022-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.801757+00:00","generated_at":"2026-06-26T11:59:43.697114+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CV Sciences reports FY2021 revenue down 18% to $20.0M; loss narrows to $18.4M","bullets":["Revenue of $20.0M for FY2021, down 18% from $24.4M in 2020.","Gross margin declined to 43.0% from 45.1%; cash fell to $1.4M from $4.5M.","Operating loss improved to $18.4M from $22.6M; adjusted EBITDA negative $10.0M.","Retail distribution expanded to 8,400+ stores from 7,300 as of Dec 31, 2021.","Launched new products; GNC distribution agreement; PPP loan forgiveness of $2.9M."],"urls":{"canonical":"https://secwatch.observer/filing/0001510964-22-000016","json":"https://secwatch.observer/filing/0001510964-22-000016.json","markdown":"https://secwatch.observer/filing/0001510964-22-000016.md","text":"https://secwatch.observer/filing/0001510964-22-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000016/0001510964-22-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000016/cvsi-20220331.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T11:59:43.697114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}